The company secured a deal to equip Rigshospitalet and Herlev Hospital with modern treatment systems over the next few years.
California-based radiotherapy equipment maker Varian Medical Systems secured a deal worth $50 million to equip the greater Copenhagen region’s two radiation oncology departments with modern treatment systems over the next few years.
Varian said it will replace linear accelerators in the oncology departments of Rigshospitalet and Herlev Hospital with 15 advanced Varian TrueBeam and Halcyon treatment machines and two ViewRay MRIdian MR-Guided Linac systems. Varian said it has taken an order for the first four TrueBeam systems in this fiscal quarter.
“This major investment shows the commitment of The Capital Region of Denmark and the Danish government to improving cancer care and will bring the latest in radiotherapy treatments to the country’s cancer patients,” Kolleen Kennedy, president of Varian’s Oncology Systems business, said in a statement. “We are delighted that Varian has been selected to equip these projects and we look forward to continuing to provide clinicians at both hospitals with advanced systems to treat cancer patients as precisely and effectively as possible.”
Varian will install the TrueBeam and Halcyon devices, which include a number of features that will prove useful to clinicians, the company said. The Varian systems feature technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. The two hospitals will also install a full suite of Varian’s treatment planning and oncology information software to manage cancer patient workflow, Varian added.
Lars Dahl Allerup, the lead buyer for The Capital Region of Denmark, which owns and operates the two hospitals, said the deal with Varian will benefit the hospitals and the patients.
“We look forward to this multi-year strategic partnership with Varian which will secure our patients and hospitals with both continuous state-of-the-art technology and the benefits from a strong research collaboration,” Allerup said in a statement.
Last year, Varian struck a deal with a Croatian cancer clinic for the company’s Edge Radiosurgery system. Varian’s system was installed at the new Radiochirurgia Zagreb Clinic in December 2016. The non-invasive system allows clinicians to attack tumors from outside the body using carefully shaped high-energy X-rays.
Last month, Varian announced five patients with brain cancer became the first patients in the US to be treated using the company’s HyperArc High Definition Radiotherapy at the University of Alabama at Birmingham Comprehensive Cancer Center. HyperArc is designed to automate and simplify sophisticated treatments such as stereotactic radiosurgery (SRS) and make them available to more cancer patients around the world.
